These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8906288)
81. A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation. Smith MJ; Garrett RH Inflamm Res; 2005 Nov; 54(11):435-50. PubMed ID: 16307217 [TBL] [Abstract][Full Text] [Related]
82. The eosinophilia-myalgia syndrome--guidelines for patient care. Hertzman PA; Kaufman LD; Love LA; Mease PJ; Philen RM; Pincus T; Rosenberg NL; Silver R; Varga J; Clauw DJ J Rheumatol; 1995 Jan; 22(1):161-3. PubMed ID: 7699664 [No Abstract] [Full Text] [Related]
83. [The role of serotonin and serotonin receptors in the pathogenesis of migraine and in the mechanisms of action of anti-migraine drugs]. Amelin AV; Skoromets AA; Ignatov IuD Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(7):55-8. PubMed ID: 10957805 [No Abstract] [Full Text] [Related]
85. The eosinophilia-myalgia syndrome and tryptophan. Belongia EA; Mayeno AN; Osterholm MT Annu Rev Nutr; 1992; 12():235-56. PubMed ID: 1503805 [No Abstract] [Full Text] [Related]
86. [Eosinophilia-myalgia syndrome]. Heuschling C Bull Soc Sci Med Grand Duche Luxemb; 1992; 129(2):17-23. PubMed ID: 1340406 [No Abstract] [Full Text] [Related]
87. Genetic and biochemical changes of the serotonergic system in migraine pathobiology. Gasparini CF; Smith RA; Griffiths LR J Headache Pain; 2017 Dec; 18(1):20. PubMed ID: 28194570 [TBL] [Abstract][Full Text] [Related]
88. Role of serotonin in therapy of depression and related disorders. Fuller RW J Clin Psychiatry; 1991 May; 52 Suppl():52-7. PubMed ID: 1674251 [TBL] [Abstract][Full Text] [Related]
89. [Scleroderma and environment. III. Eosinophilia-myalgia syndrome and L-tryptophan]. Bournerias I; Castot A Ann Dermatol Venereol; 1991; 118(12):962-8. PubMed ID: 1799247 [No Abstract] [Full Text] [Related]
93. Eosinophilia-myalgia syndrome: a recent syndrome serving as an alert to new diseases ahead. Sidransky H Mod Pathol; 1994 Sep; 7(7):806-10. PubMed ID: 7824518 [TBL] [Abstract][Full Text] [Related]
94. Use of serotonergic agents in the clinical assessment of central serotonin function. Murphy DL; Mueller EA; Garrick NA; Aulakh CS J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586 [TBL] [Abstract][Full Text] [Related]
95. Serotonin and migraine: biology and clinical implications. Hamel E Cephalalgia; 2007 Nov; 27(11):1293-300. PubMed ID: 17970989 [TBL] [Abstract][Full Text] [Related]
96. Serotonin and migraine: a reconsideration of the central theory. Panconesi A J Headache Pain; 2008 Oct; 9(5):267-76. PubMed ID: 18668197 [TBL] [Abstract][Full Text] [Related]
98. Serotonergic mechanisms in the migraine brain - a systematic review. Deen M; Christensen CE; Hougaard A; Hansen HD; Knudsen GM; Ashina M Cephalalgia; 2017 Mar; 37(3):251-264. PubMed ID: 27013238 [TBL] [Abstract][Full Text] [Related]
99. The eosinophilia-myalgia syndrome: what we know, what we think we know, and what we need to know. Clauw DJ; Pincus T J Rheumatol Suppl; 1996 Oct; 46():2-6. PubMed ID: 8895175 [No Abstract] [Full Text] [Related]